[ASAP] From Preformulative Design to in Vivo Tests: A Complex Path of Requisites and Studies for Nanoparticle Ocular Application. Part 2: In Vitro, Ex Vivo, and In Vivo Studies 🔗 Access full article via ACS Molecular Pharmaceutics Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.4c00725 Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
